| 1 |
Wood BL, Arroz M, Barnett D, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flowcytometry: optimal reagents and reporting for the flowcytometric diagnosis of hematopoietic neoplasia[J]. Cytometry B Clin Cytom, 2007,72B:S14-S22.
|
| 2 |
Craig F, Foon K. Flow cytometric immunophenotyping for hematologic neoplasms[J]. Blood, 2008,111(8):3941-3967.
|
| 3 |
Jaffe ES, Harris NL, Stein H, et al. Introduction and overview of the classification of the lymphoid neoplasms[M]//Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: Fourth Edition. Lyon: IARC Press, 2008:158-166.
|
| 4 |
Johansson U, Bloxham D, Couzens S, et al. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms[J]. Br J Haematol, 2014,165(4):455-488.
|
| 5 |
van Dongen JJ, Lhermitte L, Böttcher S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes[J]. Leukemia, 2012,26(9):1908-1975.
|
| 6 |
Kalina T, Flores-Montero J, van der Velden VH, et al. EuroFlow standardization of flowcytometer instrument settings and immunophenotyping protocols[J]. Leukemia, 2012,26(9):1986-2010.
|
| 7 |
Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications[J]. Blood, 2011,117(19):5019-5032.
|
| 8 |
Swerdlow SH, Campo E, Pileri SA, et al.The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J].Blood, 2016,127(20):2375-2390.
|
| 9 |
石远凯，孙燕，刘彤华. 中国恶性成熟淋巴细胞肿瘤诊疗规范(2015年版)[J] .中华肿瘤杂志, 2015,37(02):148-158.
|
| 10 |
D′Arena G, Musto P. Monoclonal B-cell lymphocytosis[J]. Transl Med UniSa, 2014,8:75-79.
|
| 11 |
Bairey O. Role and prognostic significance of the Ki-67 index in non-Hodgkin′s lymphoma[J]. European J Clin Med Oncol, 2010,2(2):109-115.
|
| 12 |
Wu JM, Borowitz MJ, WeirEG. The Usefulness of CD71 Expression by Flow Cytometry for Differentiating Indolent From Aggressive CD10＋ B-Cell Lymphomas[J]. Am J Clin Pathol, 2006,126:39-46.
|
| 13 |
McGowan P, Nelles N, Wimmer J, et al. Differentiating between Burkitt lymphoma and CD10＋ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system[J]. Am J Clin Pathol, 2012,137(4):665-670.
|
| 14 |
Flores-Montero J, de Tute R, Paiva B, et al. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma[J]. Cytometry B Clin Cytom, 2016,90(1):61-72.
|
| 15 |
Arroz M, Came N, Lin P, et al. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting[J]. Cytometry B Clin Cytom, 2016,90(1):31-39.
|
| 16 |
中国医师协会血液科医师分会，中华医学会血液学分会，中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2015年修订)[J]. 中华内科杂志, 2015,54(12):1066-1070.
|
| 17 |
Tembhare P, Yuan CM, Xi L, et al. Flow cytometric immunophenotypic assessment of T-cell clonality by Vβrepertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy[J]. Am J Clin Pathol, 2011,135(6):890-900.
|
| 18 |
Hunt AM, Shallenberger W, Ten Eyck SP, et al. Use of internal control T-cell populations in the flow cytometric evaluation for T-cell neoplasms[J]. Cytometry B Clin Cytom, 2016,90(5):404-414.
|
| 19 |
Morice WG, Jevremovic D, Olteanu H, et al. Chronic Lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets[J].Leukemia, 2010,24(4):881-884.
|
| 20 |
McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry[J]. Blood, 2001,98(8):2498-2507.
|
| 21 |
Li S, Juco J, Mann KP, et al. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma[J]. AmJ Clin Pathol, 2004,121(2):268-274.
|
| 22 |
Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH InternationalWorkshop[J]. Blood, 2010,116(14):e35-40.
|
| 23 |
David JA, Huang JZ. Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma[J]. Am J Clin Pathol, 2016,145(1):107-115.
|
| 24 |
Küppers R, Dührsen U, Hansmann ML. Pathogenesis, diagnosis, and treatment of composite lymphomas[J]. Lancet Oncol, 2014,15(10):e435-446.
|
| 25 |
Hussein S, Gill K, Baer LN, et al. Practical diagnostic approaches to composite plasma cell neoplasm and low grade B-cell lymphoma/clonal infiltrates in the bone marrow[J]. Hematol Oncol, 2015,33(1):31-41.
|